Home / Healthcare/ WHO and vaccine group back ‘critical’ cervical cancer shots

WHO and vaccine group back ‘critical’ cervical cancer shots


Comments / {{hitsCtrl.values.hits}} Views / Wednesday, 6 February 2019 00:00

Facebook

 


LONDON: A vaccine given to girls to protect them against a virus that causes cervical cancer is a ‘critical’ health tool and access to it should be scaled up as swiftly as possible, especially in poorer countries, cancer experts said on Monday.

Figures from the World Health Organization’s International Agency for Research on Cancer (IARC) showed an estimated 570,000 new cases of cervical cancer were diagnosed worldwide in 2018, making it the fourth most common cancer in women globally.

Each year, more than 310,000 women die from cervical cancer, and the vast majority of deaths are in poorer countries where immunisation rates against the human papillomavirus (HPV) that causes it are low.

In wealthy countries, some anti-vaccine campaigners are also persuading parents to refuse the shot for their children, leaving them at risk, IARC said.

“Unfounded rumours about HPV vaccines continue to unnecessarily delay or impede the scaling up of vaccination,” IARC’s director Elisabete Weiderpass said in a statement.

She said IARC was committed to fighting cervical cancer and “unequivocally confirms the efficacy and safety” of HPV shots.

Britain’s GSK makes an HPV vaccine called Cervarix, which targets two strains of the virus, while Merck makes a rival shot, Gardasil, which targets four strains.

In a separate statement addressed to the WHO last week, the GAVI vaccines alliance also urged greater support for HPV shots, saying it aimed to immunise 40 million girls in poorer countries against HPV by 2020.

This would avert an estimated 900,000 deaths, GAVI said.

IARC said reducing the cost of vaccines in poorer countries would play a vital role in increasing access to them. It said it was working with the generic drugmaker Serum Institute of India to develop an HPV shot that “could provide a high-quality alternative at a lower cost”.

 


Share This Article

Facebook Twitter


DISCLAIMER:

1. All comments will be moderated by the Daily FT Web Editor.

2. Comments that are abusive, obscene, incendiary, defamatory or irrelevant will not be published.

3. We may remove hyperlinks within comments.

4. Kindly use a genuine email ID and provide your name.

5. Spamming the comments section under different user names may result in being blacklisted.

COMMENTS

Today's Columnists

Emerging signals of a US recession

Wednesday, 21 August 2019

US stocks plunge on fears of an economic downturn Last week’s turbulence in financial markets was a reaction to the fresh evidence of a possible recession in the US economy. The Dow Jones Industrials Average dropped a whopping 800 points or 3% last


The 1915 pogrom: Where were all the women?

Wednesday, 21 August 2019

The 1915 anti-Muslim pogrom in Sri Lanka (then Ceylon) is usually analysed through the lenses of ethnicity, religion, or class. Gender – and specifically women – appears to be absent in the narratives on this colonial-era conflict. Such absence i


The meaning of our slogans

Wednesday, 21 August 2019

Sri Lankans undoubtedly are inclined towards slogans, and the time of elections is the high season. They appear everywhere; on walls, bus stands, huge boulders, vehicles and even on the garments worn by the campaigners. Usually we are given somewhat


“Doing something” about social media?

Wednesday, 21 August 2019

Since the tragic terrorist incidents and pogroms of April and May, concerns about social media have been reverberating throughout our society. We are under pressure to “do something,” even without fully understanding the problems we seek to solve


Columnists More

Special Report

SPECIAL REPORT MORE